Time | Session |
---|---|
08:30 | Welcome Coffee |
09:15 | Opening Remarks – Carsten Laue – Organizer |
09:20 | Welcome Address: Hugues Abriel – Vice-Rector of the University of Bern Chair: D. Theler |
09:30 | Keynote I: Paul Nioi – Senior Vice President Research Alnylam Pharmaceuticals – “New frontiers for RNAi therapeutics in neurological diseases” Chair: J. Hall |
10:10 | Translational Academic Talks Volker Thiel – EDI & University of Bern – “Lost in Translation – generation of live-attenuated viral vaccines by genome recoding” Arka Banerjee – 80SBio GmbH & University of Basel – “UniqRT: Rapid and cost effective Point of Contact RNA Diagnostics for Disease Detection and Therapy Adaptation” Özgür Genç – Translation X & University of Basel – “Targeting selective mRNA translation for a precision medicine approach in autism” Bogdan Mateescu – NeXendia & University of Zurich – “PRISM technologies: Advancing RNA Therapeutic Development with Next-Generation RNA Liquid Biopsies” Jan Nelis -Ariya Bio & ETH Zurich – “Project Delta Force – Upregulating delta globin as a new avenue to treat hemoglobinopathies” Chair: R. Pillai |
11:25 | Coffee Break |
11:55 | Panel I – How to Break Down Barriers for Translation in Academia: Daniel Blessing – HAYA Therapeutics Mathias Frederiksen – Novartis Venture Fund Raluca Flükiger – University of Geneva Roland Martin – Cellerys & University of Zurich Moderated by Ramesh Pillai |
12:25 | Company Presentations I: Agnese Pisano – Inofea – “Empowering nucleic acids processing enzymes” Klaas Zuideveld – Versameb – “Versameb – transforming to a clinical stage RNA company” Daniel Blessing – Haya Therapeutics – “Precision Medicines Targeting the Dark Genome – For the Heart and Beyond” Chair: C. Laue |
12:45 | Lunch & Poster Session & Networking |
14:00 | Keynote II: Martin Jinek – CRISPR genome engineering co-discoverer, University of Zurich – “CRISPR genome editors: mechanisms, engineering and therapeutic applications” Chair: R. Pillai |
14:40 | Young Scientists Career Talks: Florian Aeschimann – Principal Scientist, CSL Behring Christian Berk – Patent Professional, E. Blum & Co. AG Nana Diarra dit Konté – Marketing Manager, bNovate Technologies Deni Subasic – Network Innovation Director, Roche Chair: D. Theler |
15:00 | Sonja Merkas – Freelance Consultant – “RNA Therapeutics – Navigating the Science, Manufacturing, and Market Dynamics” Chair: J. Hall |
15:10 | Panel II: Communication Rainer Borer – Head of Communications, ETH Zürich Therese Lüthi – Science Journalist & Editor NZZ am Sonntag Steve Pascolo – mRNA vaccination pioneer, co-founder CureVac, University Hospital Zurich Volker Thiel – Coronavirus researcher & member of the Swiss Covid Science Task Force, EDI & University of Bern Moderated by Dominik Theler |
15:40 | Coffee Break |
16:10 | Ingrid B. Müller – Swiss Federal Institute of Intellectual Property – “Patentanalyses in the field of RNA therapeutics” Chair: D. Theler |
16:20 | Company Presentations II: Morten Lindow – Roche – “Roche’s RNAHub in Basel – progress on grand challenges of oligonucleotide drug discovery” Tomaz Einfalt – Novartis – “State of the Art siRNA – Chemistry and Delivery” Florian Aeschimann – CSL Behring – “Gene therapy research at CSL Behring” Giovanni Calderisi – Bachem – “Therapeutic Oligonucleotides – Unraveling Complexity from High Purity to Intricate Mixtures” Chair: C. Laue |
17:15 | Panel III – Technological Trends & Needs Jørgen Kjems – Aarhus University Sonja Merkas – Freelance Consultant Klaas Zuideveld – Versameb Morten Lindow – Roche Moderated by Jonathan Hall |
17:45 | Concluding Remarks – Carste Laue – Organizer |
17:50 | Apéro |